<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="28/04/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10022897"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10022897</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Other" id="A1">Activation</term>-dependent <term sem="Other" id="T1">transcriptional regulation</term> of the <term sem="DNA_domain_or_region" id="T2" lex="human_Fas_promoter">human Fas promoter</term> requires <term sem="Other" id="T3" lex="NF-kappaB_p50-p65_recruitment"><term sem="Protein_complex" id="T4" lex="NF-kappaB_p50-p65">NF-kappaB p50-p65</term> recruitment</term>.</sentence>
<event id="E1">
<type class="Regulation" />
<theme idref="T2" />
<clue>Activation-dependent transcriptional <clueType>regulation</clueType> <linkTheme>of</linkTheme> the human Fas promoter requires NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E34">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Activation-<clueType>dependent</clueType> transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="E102" />
<clue>Activation-dependent transcriptional regulation of the human Fas promoter <clueType>requires</clueType> NF-kappaB p50-p65 recruitment.</clue>
</event>
<event id="E102">
<type class="Positive_regulation" />
<theme idref="T4" />
<clue>Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 <clueType>recruitment</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T5" lex="Fas">Fas</term> (<term sem="Protein_molecule" id="T6" lex="CD95">CD95</term>) and <term sem="Protein_molecule" id="T7" lex="Fas_ligand">Fas ligand</term> (<term sem="Protein_molecule" id="T8" lex="CD95L">CD95L</term>) are an interacting <term sem="Other" id="T9" lex="receptor-ligand_pair">receptor-ligand pair</term> required for <term sem="Other" id="T10" lex="immune_homeostasis">immune homeostasis</term>.</sentence>
<event id="E3">
<type class="Binding" />
<theme idref="T6" />
<theme idref="T8" />
<clue>Fas (CD95) and Fas ligand (CD95L) are an <clueType>interacting receptor-ligand pair</clueType> required for immune homeostasis.</clue>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="T10" />
<cause idref="E3" />
<clue>Fas (CD95) and Fas ligand (CD95L) are an interacting receptor-ligand pair <clueType>required</clueType> <linkTheme>for</linkTheme> immune homeostasis.</clue>
</event>
<sentence id="S3"><term sem="Other" id="T11" lex="lymphocyte_activation"><term sem="Cell_natural" id="A2">Lymphocyte</term> activation</term> results in the upregulation of <term sem="Other" id="T12" lex="Fas_expression"><term sem="Protein_molecule" id="T13" lex="Fas">Fas</term> expression</term> and the acquisition of sensitivity to <term sem="Protein_molecule" id="T15" lex="FasL">FasL</term>-mediated <term sem="Other" id="A3">apoptosis</term>.</sentence>
<event id="E5">
<type class="Physiological_process" />
<theme idref="A2" />
<clue>Lymphocyte <clueType>activation</clueType> results in the upregulation of Fas expression and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event id="E6">
<type class="Gene_expression" />
<theme idref="T13" />
<clue>Lymphocyte activation results in the upregulation of Fas <clueType>expression</clueType> and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="E6" />
<cause idref="E5" />
<clue>Lymphocyte activation <clueType>results in</clueType> the <clueType>upregulation</clueType> <linkTheme>of</linkTheme> Fas expression and the acquisition of sensitivity to FasL-mediated apoptosis.</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="A3" />
<cause idref="T15" />
<clue>Lymphocyte activation results in the upregulation of Fas expression and the acquisition of sensitivity to FasL-<clueType>mediated</clueType> apoptosis.</clue>
</event>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="E8" />
<cause idref="E5" />
<clue>Lymphocyte activation <clueType>results in</clueType> the upregulation of Fas expression and the <clueType>acquisition of sensitivity</clueType> <linkTheme>to</linkTheme> FasL-mediated apoptosis.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S4">Although <term sem="Protein_molecule" id="A4">Fas</term> upregulation is central to the preservation of <term sem="Other" id="A5">immunologic tolerance</term>, little is known about the <term sem="Other" id="T16" lex="molecular_machinery">molecular machinery</term> underlying this process.</sentence>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="A4" />
<clue>Although Fas <clueType>upregulation</clueType> is central to the preservation of immunologic tolerance, little is known about the molecular machinery underlying this process.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="A5" />
<cause idref="E10" />
<clue>Although Fas upregulation is <clueType>central to</clueType> the <clueType>preservation</clueType> <linkTheme>of</linkTheme> immunologic tolerance, little is known about the molecular machinery underlying this process.</clue>
</event>
<sentence id="S5">To investigate the events involved in <term sem="Other" id="A6">activation</term>-induced <term sem="Other" id="T17" lex="Fas_upregulation"><term sem="Protein_molecule" id="T18" lex="Fas">Fas</term> upregulation</term>, we have examined <term sem="Other" id="T19" lex="mRNA_accumulation">mRNA accumulation</term>, <term sem="Other" id="T20" lex="fas_promoter_activity">fas promoter activity</term>, and <term sem="Other" id="T21" lex="protein_expression">protein expression</term> in the <term sem="Cell_cultured" id="T22" lex="Jurkat_T-cell_line">Jurkat T-cell line</term> treated with <term sem="Organic_compound_other" id="T23" lex="phorbol_myristate_acetate">phorbol myristate acetate</term> and <term sem="Organic_compound_other" id="T24" lex="ionomycin">ionomycin</term> (<term sem="Organic_compound_other" id="T25" lex="P/I">P/I</term>), pharmacological mimics of <term sem="Other" id="T26" lex="T-cell_receptor_activation"><term sem="Protein_family_or_group" id="T27" lex="T-cell_receptor">T-cell receptor</term> activation</term>.</sentence>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T18" />
<clue>To investigate the events involved in activation-induced Fas <clueType>upregulation</clueType>, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="A6" />
<clue>To investigate the events involved in activation-<clueType>induced</clueType> Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event uncertainty="doubtful" id="E14">
<type class="RNA_metabolism" />
<theme idref="T18" />
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined <corefTheme>mRNA</corefTheme> <clueType>accumulation</clueType>, fas promoter activity, and protein expression <clueLoc>in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I)</clueLoc>, pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event uncertainty="doubtful" id="E15">
<type class="Gene_expression" />
<theme idref="T18" />
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and <corefTheme>protein</corefTheme> <clueType>expression</clueType> <clueLoc>in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I)</clueLoc>, pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event id="E115">
<type class="Artificial_process" />
<theme idref="T22" />
<theme idref="T23" />
<theme idref="T25" />
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line <clueType>treated</clueType> <linkTheme>with</linkTheme> phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation.</clue>
</event>
<event id="E215">
<type class="Positive_regulation" />
<theme idref="T27" />
<clue>To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor <clueType>activation</clueType>.</clue>
</event>
<sentence id="S6">Although <term sem="Cell_cultured" id="T28" lex="resting_Jurkat_cell">resting Jurkat cells</term> express <term sem="Protein_molecule" id="T29" lex="Fas">Fas</term>, <term sem="RNA_molecule" id="T30" lex="Fas_mRNA"><term sem="Protein_molecule" id="T31" lex="Fas">Fas</term> mRNA</term> was induced approximately 10-fold in 2 h upon <term sem="Organic_compound_other" id="T32" lex="P/I">P/I</term> stimulation.</sentence>
<event id="E18">
<type class="Gene_expression" />
<theme idref="T29" />
<clue>Although <clueLoc>resting Jurkat cells</clueLoc> <clueType>express</clueType> Fas, Fas mRNA was induced approximately 10-fold in 2 h upon P/I stimulation.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="T30" />
<cause idref="T32" />
<clue>Although resting <clueLoc>Jurkat cells</clueLoc> express Fas, Fas mRNA was <clueType>induced</clueType> approximately 10-fold <clueTime>in 2 h</clueTime> <linkCause>upon</linkCause> P/I stimulation.</clue>
</event>
<sentence id="S7">Using <term sem="DNA_family_or_group" id="T33" lex="sequential_deletion_mutant">sequential deletion mutants</term> of the <term sem="DNA_domain_or_region" id="T34" lex="human_fas_promoter">human fas promoter</term> in transient transfection assays, we identified a <term sem="DNA_domain_or_region" id="T35" lex="47-bp_sequence">47-bp sequence</term> (<term sem="DNA_domain_or_region" id="T36" lex="positions_-306_to_-260">positions -306 to -260</term> relative to the <term sem="Polynucleotide" id="T37" lex="ATG">ATG</term>) required for <term sem="Other" id="A8">activation</term>-driven <term sem="Other" id="T14"><term sem="Protein_molecule" id="A7">fas</term> upregulation</term>.</sentence>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="A8" />
<clue>Using sequential deletion mutants of the human fas promoter in transient transfection assays, we identified a 47-bp sequence (positions -306 to -260 relative to the ATG) required for activation-<linkCause>driven</linkCause> fas <clueType>upregulation</clueType>.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E20" />
<cause idref="T35" />
<clue>Using sequential deletion mutants of the human fas promoter <clueExperiment>in transient transfection assays</clueExperiment>, we identified a 47-bp sequence (positions -306 to -260 relative to the ATG) <clueType>required</clueType> <linkTheme>for</linkTheme> activation-driven fas upregulation.</clue>
</event>
<sentence id="S8"><term sem="Other" id="T39" lex="sequence_analysis">Sequence analysis</term> revealed the presence of a previously <term sem="DNA_domain_or_region" id="T40" lex="unrecognized_composite_binding_site">unrecognized composite binding site</term> for both the <term sem="Protein_molecule" id="T41" lex="Sp1">Sp1</term> and <term sem="Protein_complex" id="T42" lex="NF-kappaB">NF-kappaB</term> <term sem="Protein_family_or_group" id="T43" lex="transcription_factor">transcription factors</term> at <term sem="DNA_domain_or_region" id="T44" lex="position_-295_to_-286">positions -295 to -286</term>.</sentence>
<sentence id="S9"><term sem="Other" id="T45" lex="electrophoretic_mobility_shift_assay">Electrophoretic mobility shift assay</term> (<term sem="Other" id="T46" lex="EMSA">EMSA</term>) and supershift analyses of this region documented constitutive binding of <term sem="Protein_molecule" id="T47" lex="Sp1">Sp1</term> in unactivated nuclear extracts and inducible binding of <term sem="Protein_complex" id="T48" lex="p50-p65_NF-kappaB_heterodimer">p50-p65 <term sem="Protein_complex" id="T49" lex="NF-kappaB">NF-kappaB</term> heterodimers</term> after <term sem="Organic_compound_other" id="T50" lex="P/I">P/I</term> activation.</sentence>
<event id="E22">
<type class="Binding" />
<theme idref="T40" />
<theme idref="T47" />
<clue><clueExperiment>Electrophoretic mobility shift assay (EMSA) and supershift analyses</clueExperiment> of <corefTheme>this region</corefTheme> documented constitutive <clueType>binding</clueType> <linkTheme>of</linkTheme> Sp1 <clueLoc>in unactivated nuclear extracts</clueLoc> and inducible binding of p50-p65 NF-kappaB heterodimers after P/I activation.</clue>
</event>
<event id="E23">
<type class="Binding" />
<theme idref="T40" />
<theme idref="T48" />
<clue>Electrophoretic mobility shift assay (EMSA) and supershift analyses of <corefTheme>this region</corefTheme> documented constitutive binding of Sp1 in unactivated nuclear extracts and inducible <clueType>binding</clueType> <linkTheme>of</linkTheme> p50-p65 NF-kappaB heterodimers after P/I activation.</clue>
</event>
<event id="E24">
<type class="Physiological_process" />
<theme idref="T22" />
<cause idref="T50" />
<clue>Electrophoretic mobility shift assay (EMSA) and supershift analyses of this region documented constitutive binding of Sp1 in unactivated nuclear extracts and inducible binding of p50-p65 NF-kappaB heterodimers after P/I <clueType>activation</clueType>.</clue>
<comment>No corefTheme</comment></event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="E23" />
<cause idref="E24" />
<clue><clueExperiment>Electrophoretic mobility shift assay (EMSA) and supershift analyses</clueExperiment> of this region documented constitutive binding of Sp1 in unactivated nuclear extracts and <clueType>inducible</clueType> binding of p50-p65 NF-kappaB heterodimers <linkCause>after</linkCause> P/I activation.</clue>
</event>
<sentence id="S10"><term sem="Protein_molecule" id="T51" lex="Sp1">Sp1</term> and <term sem="Protein_complex" id="T52" lex="NF-kappaB">NF-kappaB</term> <term sem="Other" id="T53" lex="transcription_factor_binding">transcription factor binding</term> was shown to be mutually exclusive by <term sem="Other" id="T55" lex="EMSA">EMSA</term> displacement studies with purified recombinant <term sem="Protein_molecule" id="T56" lex="Sp1">Sp1</term> and recombinant <term sem="Protein_molecule" id="T57" lex="p50">p50</term>.</sentence>
<event id="E26">
<type class="Binding" />
<theme idref="T51" />
<theme idref="T40" />
<clue>Sp1 and NF-kappaB transcription factor <clueType>binding</clueType> was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.</clue>
<comment>No corefTheme</comment></event>
<event id="E27">
<type class="Binding" />
<theme idref="T52" />
<theme idref="T40" />
<clue>Sp1 and NF-kappaB transcription factor <clueType>binding</clueType> was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.</clue>
<comment>No corefTheme</comment></event>
<event id="E28">
<type class="Negative_regulation" />
<theme idref="E26" />
<cause idref="E27" />
<clue>Sp1 and NF-kappaB transcription factor binding was shown to be <clueType>mutually exclusive</clueType> <clueExperiment>by EMSA displacement studies</clueExperiment> with purified recombinant Sp1 and recombinant p50.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E27" />
<cause idref="E26" />
<clue>Sp1 and NF-kappaB transcription factor binding was shown to be <clueType>mutually exclusive</clueType> <clueExperiment>by EMSA displacement studies</clueExperiment> with purified recombinant Sp1 and recombinant p50.</clue>
</event>
<sentence id="S11">The functional contribution of the <term sem="DNA_domain_or_region" id="T58" lex="kappaB-Sp1_composite_site">kappaB-<term sem="Protein_molecule" id="T59" lex="Sp1">Sp1</term> composite site</term> in <term sem="Organic_compound_other" id="T62" lex="P/I">P/I</term>-inducible <term sem="Other" id="T38"><term sem="DNA_domain_or_region" id="A9">fas promoter</term> activation</term> was verified by using kappaB-<term sem="Polynucleotide" id="T63" lex="Sp1_concatamer"><term sem="Protein_molecule" id="T64" lex="Sp1">Sp1</term> concatamers</term> (<term sem="DNA_domain_or_region" id="T65" lex="-295_to_-286">-295 to -286</term>) in a <term sem="DNA_molecule" id="T66" lex="thymidine_kinase_promoter-driven_reporter_construct">thymidine kinase promoter-driven reporter construct</term> and <term sem="DNA_family_or_group" id="T67" lex="native_promoter_construct">native promoter constructs</term> in <term sem="Cell_cultured" id="T68" lex="Jurkat_cell">Jurkat cells</term> overexpressing <term sem="Protein_molecule" id="T69" lex="IkappaB-alpha">IkappaB-alpha</term>.</sentence>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="A9" />
<cause idref="T62" />
<clue>The functional contribution of the kappaB-Sp1 composite site in P/I-<linkCause>inducible</linkCause> fas promoter <clueType>activation</clueType> was verified by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB-alpha.</clue>
</event>
<event id="E30">
<type class="Correlation" />
<theme idref="E29" />
<theme idref="T58" />
<clue>The functional <clueType>contribution</clueType> <linkTheme>of</linkTheme> the kappaB-Sp1 composite site <linkTheme>in</linkTheme> P/I-inducible fas promoter activation was verified by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs <clueLoc>in Jurkat cells overexpressing IkappaB-alpha</clueLoc>.</clue>
</event>
<sentence id="S12">Site-directed mutagenesis of the critical <term sem="Nucleotide" id="T70" lex="guanine_nucleotide">guanine nucleotides</term> in the <term sem="DNA_domain_or_region" id="T71" lex="kappaB-Sp1_element">kappaB-<term sem="Protein_molecule" id="T72" lex="Sp1">Sp1</term> element</term> documented the essential role of this site in <term sem="Other" id="A11">activation</term>-dependent <term sem="Other" id="T54"><term sem="DNA_domain_or_region" id="A10">fas promoter</term> induction</term>.</sentence>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="A10" />
<cause idref="A11" />
<clue>Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element documented the essential role of this site in activation-<linkCause>dependent</linkCause> fas promoter <clueType>induction</clueType>.</clue>
</event>
<event id="E32">
<type class="Positive_regulation" />
<theme idref="E31" />
<cause idref="T71" />
<clue>Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element documented the <clueType>essential role</clueType> <linkCause>of</linkCause> <corefCause>this site</corefCause> <linkTheme>in</linkTheme> activation-dependent fas promoter induction.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
